ERIC JONASCH to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications ERIC JONASCH has written about Antineoplastic Agents, Immunological.
Connection Strength
0.574
-
Updates to the Management of Kidney Cancer. J Natl Compr Canc Netw. 2018 05; 16(5S):639-641.
Score: 0.327
-
The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC). J Immunother Cancer. 2019 12 20; 7(1):354.
Score: 0.092
-
Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake. Commun Biol. 2019; 2:386.
Score: 0.091
-
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma. Nat Commun. 2021 11 04; 12(1):6375.
Score: 0.026
-
Recommendations for the Management of Rare Kidney Cancers. Eur Urol. 2017 12; 72(6):974-983.
Score: 0.019
-
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma. J Immunother Cancer. 2016; 4:81.
Score: 0.018